IL16 and ovarian carcinoma: Moradi et al. [29] analyzed concentrations of TNF-alpha, interleukin 1 and 6(IL-1and IL-6) in serum and peritoneal fluid from healthy women and ovarian cancer patients, and demonstrated that presence of malignancy was associated with a significant increase in all these parameters.